Symbols

Symbols

TLPH

TLPH

Talphera Q3 2025 Earnings Call Transcript: Key Highlights and Business Updates

Talphera Announces Q3 2025 Financial Results, $21.3mln Cash, PMA Approval Expected Late 2026.

Tuesday Oct 21, 2025

Strategy Pref A 10.00%'s 15min chart triggers KDJ Golden Cross, Bullish Marubozu

T. Rowe Price Group's 15min Chart Triggers MACD and KDJ Death Cross.

Graham Holdings's 15-min chart signals bearish trends with MACD Death Cross, RSI Overbought.

Sensient Technologies's 15min chart shows Bollinger Bands Narrowing and Bearish Marubozu signal.

Talphera Appoints CorMedix CEO Joe Todisco to Board of Directors.

Talphera Appoints Joe Todisco to Board of Directors as Part of CorMedix Investment

Monday Sep 22, 2025

Talphera Files Prospectus for Resale of Up to 30.88M Shares by Selling Stockholders

Thursday Sep 18, 2025

Rock Springs Capital Management Acquires 3.3M Shares in Talphera Inc.

Wednesday Sep 10, 2025

Talphera, Inc. shares fall 2.34% premarket after Ninth Circuit affirms dismissal of securities fraud suit.

Tuesday Sep 09, 2025

Talphera, Inc. shares rise 10.50% intraday after Ninth Circuit affirmed dismissal of securities fraud suit.

Talphera, Inc. shares fall 16.61% premarket after announcing private placement financing of up to $29 million.

Healthcare Stocks in Focus: Rapport Therapeutics and Beyond Air Lead Gainers

Monday Sep 08, 2025

Talphera, Inc. shares fall 7.81% after-hours following private placement financing announcement.

Talphera Secures Up to $29M in Private Placement Led by CorMedix.

Talphera, Inc. shares rise 30.42% intraday after announcing private placement financing of up to $29 million.

Talphera (TLPH) up more than 100% since Aug 19

CorMedix invests $5mln in Talphera, acquires 9.09mln shares.

CorMedix Invests $5 Million in Talphera for Niyad Anticoagulant Study